Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Facility inspections increase

This article was originally published in The Gray Sheet

Executive Summary

FDA's device center exceeded facility inspection goals last year by at least 20%, according to CDRH's 1annual report for fiscal 2006. The agency conducted 1,299 domestic inspections of device firms (1,066 planned), as well as 207 foreign inspections (168 planned) and 336 bioresearch monitoring (BIMO) inspections (278 planned), the report states. The increased number of inspections is part of the center's enhanced postmarket oversight to ensure the safety and effectiveness of products, CDRH Director Dan Schultz says. The document notes that CDRH also exceeded by 15% its 2006 goal of obtaining a 71% participation rate from the 350 health care facilities participating in the Medical Product Surveillance Network (MedSun) (2"The Gray Sheet" July 25, 2006, p. 26)

You may also be interested in...

House Panel Probes FDA Inspections Of Overseas Device Facilities

With Congress increasingly focused on improving safety checks for products imported into the United States, FDA oversight of foreign device manufacturing facilities is getting pulled into the mix

FDA Oversight Of Clinical Trials Needs More Muscle, OIG Report Says

FDA lacks the data it needs to protect patients enrolled in clinical trials, says a Sept. 28 1report from the HHS Office of Inspector General

FDA MedSun Focus Shifts From Recruitment To Educational Outreach

FDA says that over the next year it will work to improve the quality and quantity of reports from current Medical Product Surveillance Network (MedSun) participants, rather than recruit more




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts